iSchemaView Launches RAPID U

What Kind of Equipment is Used to Analyze DNA?

Below are some of a few basic processes followed throughout DNA testing. The general procedure entails:  • Isolating DNA from a sample containing the needed...

mJOULE Launches in the United Kingdom Reports Sciton

"Sciton is dedicated to worldwide support and growth. We continue to demonstrate our commitment to developing high quality devices and marketing efforts for our physician and medspa partners worldwide." says Lacee J. Naik, Vice President of Marketing and Public Relations.

FDA Issues Draft Guidance on Remanufacturing and Discussion Paper Seeking Feedback on Cybersecurity Servicing of Medical Devices

With this in mind, the FDA is issuing today's draft guidance to help clarify whether activities performed on medical devices are likely remanufacturing as well as a discussion paper on cybersecurity servicing of devices.

The company has launched RAPID U, a training certification program for iSchemaView’s RAPID technology. An imaging standard around the world, RAPID is the platform designed to provide physicians with fast, fully automated, and easy-to-interpret imaging that facilitates clinical decision-making around stroke.

Powered by a mobile-first learning management system, RAPID U provides role-based learning paths for various members of stroke care teams, including imaging technologists, stroke coordinators, neuroradiologists, neurologists and neurointerventionalists. The program is resource-rich for a robust education. It is enhanced with videos, case studies, publications, and clinical trials information across 15 courses, which cover all aspects of RAPID modules and products, and is supplemented with live sessions.

“All aspects of the RAPID U certification program were developed by RAPID clinical and technology experts. It is unique, in that stroke care teams will be able to learn advanced imaging from the experts,” said Dr. Greg Albers, professor of Neurology at Stanford University, director of the Stanford Stroke Center and cofounder of iSchemaView. “iSchemaView is very excited to offer free RAPID certification to all customers via this new learning platform. As the availability of advanced stroke imaging continues to expand, it is vital for hospitals to have skilled individuals on their stroke care teams. RAPID U will help ensure that stroke care team members are fully trained on how to use RAPID effectively, and have a positive impact on patient outcomes.”

RAPID U is accessible from the desktop and mobile apps. This allows the stroke team to take courses and obtain certificates at their own pace, when and where they choose. Clinicians can become RAPID certified following the successful completion of each course, and can have the option to continue on to more advanced courses.

“Moving forward, RAPID U will provide increased visibility into clinical team readiness,” said Anil Singhal, MD, SVP, Worldwide Operations at iSchemaView. “This will allow an understanding of which modules are of particular interest, and move on to more advanced training as needed. Most importantly, this educational program will enable more members of the stroke care team to optimize RAPID in reducing the debilitating impacts of stroke.”

Developed by leading stroke experts, RAPID technology has been selected for use in several groundbreaking trials that have changed treatment guidelines issued by both the American Heart Association and American Stroke Association. The RAPID Artificial Intelligence framework combines deep learning, machine learning and expert feature extraction. Together these provide unparalleled sensitivity and specificity across stroke modules (CT perfusion, MR diffusion and perfusion, CTA and CT ASPECT scoring). Results are then delivered by the RAPID Intelligence Services Platform via PACS, email, text, the RAPID app or corporate partner workflow systems.



Hyperfine Adds Medtech Leader and Visionary Scott Huennekens as Executive Chairman

Mr. Huennekens’ public boards include Chairman of Acutus Medical (IPO August 2020); Chairman of Envista (IPO September 2019); and board member of Nuvasive. He also serves as a board member and past Chairman of the Medical Device Manufacturer’s Association (MDMA).

One Drop Reports Carrie Siragusa, CPA Appointed VP of Commercial Strategy, Biosensor

Formerly Head of Innovation and Diabetes Portfolio at Sanofi, Siragusa will be part of a team bringing a multi-analyte dermal sensor (biosensor) with continuous health sensing capabilities to market with a mission to provide broader access to continuous glucose monitoring.

Barbara Moorhouse Appointed as Medica Non-Executive Director

Barbara has extensive business and management experience in the private, public, and regulated sectors.

Subscribe to Medical Device News Magazine here.

Related Articles